Sun Pharmaceutical Industries
BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01028 | Pharmaceuticals
- Directors Report
- Chairman's Speech
- Auditors Report
- Notes To Accounts
- Accounting Policy
- Finished Products
- Raw Materials
| Auditor's Report | Year End : Mar '09 |
1. We have audited the attached Balance Sheet of Sun Pharmaceutical
Industries Limited (the Company) as at March 31, 2009, and also the
Profit and Loss Account and the Cash flow statement for the year ended
on that date annexed thereto. These financial statements are the
responsibility of the Company’s management. Our responsibility is to
express an opinion on these financial statements based on our audit.
2. We conducted our audit in accordance with auditing standards
generally accepted in India. Those Standards require that we plan and
perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. An audit
includes examining, on a test basis, evidence supporting the amounts
and disclosures in the financial statements. An audit also includes
assessing the accounting principles used and significant estimates made
by management, as well as evaluating the overall financial statement
presentation. We believe that our audit provides a reasonable basis for
our opinion.
3. As required by the Companies (Auditors’ Report) Order, 2003 issued
by the Central Government of India in terms of sub- section (4A) of
section 227 of the Companies Act, 1956, we enclose in the Annexure, a
statement on the matters specified in paragraphs 4 and 5 of the said
Order.
4. Further to our comments in the Annexure referred to in Para 3
above, we report that:
(i) we have obtained all the information and explanations, which to the
best of our knowledge and belief were necessary for the purposes of our
audit;
(ii) in our opinion, proper books of account as required by law have
been kept by the Company so far as appears from our examination of
those books;
(iii) the balance sheet, profit and loss account and cash flow
statement dealt with by this report are in agreement with the books of
account;
(iv) in our opinion, the balance sheet, profit and loss account and
cash flow statement dealt with by this report comply with the
accounting standards referred to in sub-section (3C) of Section 211 of
the Companies Act, 1956;
(v) on the basis of written representations received from directors as
on March 31, 2009 and taken on record by the Board of Directors, we
report that none of the directors is disqualified as on March 31, 2009
from being appointed as a director in terms of clause (g) of
sub-section (1) of Section 274 of the Companies Act, 1956;
(vi) in our opinion and to the best of our information and according to
the explanations given to us, the said accounts read together with
notes thereon, give the information required by the Companies Act,
1956, in the manner so required and give a true and fair view in
conformity with the accounting principles generally accepted in India:
(a) in the case of the balance sheet, of the state of affairs of the
Company as at March 31, 2009
(b) in the case of the profit and loss account, of the profit for the
year ended on that date; and
(c) in the case of the cash flow statement, of the cash flows for the
year ended on that date.
ANNEXURE TO THE AUDITORS REPORT
(Referred to in paragraph 3 of our report of even date) Sun
Pharmaceutical Industries Limited
1. In our opinion and according to the information and explanations
given to us, the nature of the Company’s business / activities during
the year is such that clauses xiii, xiv, xviii, xix and xx of paragraph
4 of the Companies (Auditors’ Report) Order, 2003, are not applicable
to the Company.
2. In respect of its fixed assets:
(i) The Company has maintained proper records showing full particulars,
including quantitative details and situation of fixed assets.
(ii) As explained to us, some of the fixed assets of the Company have
been physically verified during the year by the management in
accordance with a phased program of verification designed to cover all
assets over a period of three years, which in our opinion, is
reasonable having regard to the size of the Company and the nature of
its assets. The discrepancies noticed on such verification were not
material and have been properly dealt with in the books of account.
(iii) Although some of the fixed assets have been disposed off during
the year, in our opinion and according to the information and
explanations given to us, the ability of the company to continue as a
going concern is not affected.
3. In respect of its inventories:
(i) As explained to us, inventories (excluding inventories lying with
third parties) were physically verified by the management at reasonable
intervals during the year. In respect of inventories lying with third
parties, these have substantially been confirmed by them. In our
opinion the frequency of verification is reasonable.
(ii) In our opinion and according to the information and explanations
given to us, the procedures of physical verification of inventories
followed by the management were reasonable and adequate in relation to
the size of the Company and the nature of its business.
(iii) In our opinion and according to the information and explanations
given to us, the Company has maintained proper records of its
inventories and no material discrepancies were noticed on physical
verification.
4. The Company had not granted or taken any loan, secured or
unsecured, to or from Companies, firms or other parties covered in the
register maintained under section 301 of the Companies Act, 1956.
5. In our opinion and according to the information and explanations
given to us, there are adequate internal control systems commensurate
with the size of the company and nature of its business with regard to
purchase of inventory and fixed assets and for sale of goods and
services and we have not observed any continuing failure to correct
major weaknesses in such internal control systems.
6. In respect of contracts or arrangements entered in the register
maintained in pursuance of section 301 of the Companies Act, 1956, to
the best of our knowledge and belief and according to the information
and explanations given to us:
(i) The particulars of contract or arrangements referred to in Section
301 that needed to be entered into the register, maintained under the
said section have been so entered.
(ii) Where each such transaction (excluding loans reported under
paragraph 4 above) is in excess of Rs. 5 lakhs in respect of any party,
the transactions have been made at prices which are prima facie
reasonable having regard to prevailing market prices at the relevant
time, except that reasonableness could not be ascertained where
comparable quotations are not available having regards to the
specialized nature of some of the transactions of the company.
7. In our opinion and according to the information and explanations
given to us the Company has not accepted any deposits within the
meaning of Section 58A and 58AA or any other relevant provisions of the
Companies Act, 1956 and the Companies (Acceptance of Deposits) Rules,
1975 with regard to deposits accepted from the public. No Order has
been passed by the Company Law Board or National Company Law Tribunal
or Reserve Bank of India or any Court or any other Tribunal.
8. In our opinion, the internal audit functions carried out during the
year by firms of Chartered Accountants appointed by the management have
been commensurate with the size of the Company and the nature of its
business.
9. We have broadly reviewed the books of accounts and records
maintained by the Company relating to manufacture of formulation and
bulk drug products pursuant to the Order made by the Central Government
for maintenance of cost records under section 209 (1)(d) of the
Companies Act, 1956 and are of the opinion that prima facie the
prescribed accounts and records have been made and maintained. We have,
however, not made a detailed examination of the records with a view to
determining whether they are accurate or complete. To the best of our
knowledge and according to the information and explanations given to
us, the Central Government has not prescribed the maintenance of cost
records for any other product of the Company.
10. According to the information and explanations given to us in
respect of statutory dues:
(i) the Company has been regular in depositing undisputed statutory
dues, including, Investor Education and Protection Fund, Employees’
State Insurance, Income tax, Sales tax, Wealth Tax, Service Tax, Custom
Duty, Excise Duty, cess and other material statutory dues with the
appropriate authorities during the year. There were no undisputed dues
that were outstanding as at March 31, 2009 for a period of more than
six months from the date they became payable.
(ii) According to the information and explanations given to us, the
details of disputed sales tax, income tax, service tax, custom duty and
excise duty, which have not been deposited as at March 31, 2009 on
account of any dispute, are as under:
Statute & Nature of Dues Financial Year to which the
matter pertains
The Central Excise Act
Excise Duty, Interest & Penalty 2002-03, 2004-05, 2005-06,
2006-07, 2007-08, 2008-09
1997-98, 1998-99, 1999-00, 2000-01,
2002-03, 2003-04, 2004-05, 2005-06,
2006-07, 2007-08
1998-99
2001-02
Customs Act, 1962
Custom Duty, Penalty & Interest 2000-01
Sales Tax Act
Sales Tax, Interest and Penalty 1994-95, 1998-99, 1999-00, 2000-01,
2001-02, 2002-03, 2003-04
1988-89 to 1991-92, 1997-98,
1999-00, 2001-02
1981-82 to 1985-86
Income Tax Act
Income tax and Interest 1995-96, 2003-04
2003-04
Service Tax
Service tax 2005-06
ESI Act
Contribution and Interest 1987 to 1992
DPCO
DPEA and interest 1981-1987
Forum where dispute Amount
is pending Rs. in Million
Commissioner 44.4
Tribunal 187.3
High Court 0.1
Supreme Court 0.2
Settlement Commission 10.7
Assistant / Deputy / 6.0
Joint Commissioner
Tribunal 4.4
High Court 0.7
Tribunal 0.9
Commissioner 6.6
Commissioner 1.9
Appellate authority 0.2
DPLRC 14.0
There were no unpaid disputed dues in respect of wealth tax and cess
during the year.
11. In our opinion and according to information and explanations given
to us, the company does not have any accumulated losses as at the end
of the year. The Company has not incurred cash losses during the
financial year covered by our audit and the immediately preceding
financial year.
12. In our opinion and according to the information and explanation
given to us, the Company has not defaulted in repayment of dues to
financial institutions and banks. The Company has not obtained any
borrowings by way of debentures.
13. In our opinion, the Company has maintained adequate documents and
records where it has granted loans and advances on the basis of
security by way of pledge of shares. The Company has not granted any
loans and advances on the basis of security by way of pledge of
debentures and other securities.
14. In our opinion and according to the information and explanation
given to us, the terms and conditions of the guarantees given by the
Company for loan taken by others from banks and financial institutions,
are not prima facie prejudicial to the interest of the Company.
15. To the best of our knowledge and belief and according to the
information and explanations given to us, in our opinion, term loans
availed by the Company were, prima facie, applied by the Company during
the year for the purposes for which the loans were obtained other than
temporary deployment pending application.
16. According to the information and explanations given to us and on
an overall examination of the balance sheet of the Company, we report
that the funds raised on short term basis have, prima facie, not been
used during the year for long term investment.
17. To the best of our knowledge and belief and according to the
information and explanation given to us, no fraud on or by the Company
was noticed or reported during the year.
For Deloitte Haskins & Sells Chartered Accountants
K. A. Katki
Partner
Place: Mumbai
Date : May 30, 2009 (Membership No. 038568)
|
|
![]() | |
| Source : Religare Technova | |
![]() | |




Online










